LakeShore Biopharma Ltd Statistics Share Statistics LakeShore Biopharma Ltd has 41.21M
shares outstanding. The number of shares has increased by -90%
in one year.
Shares Outstanding 41.21M Shares Change (YoY) -90% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 8.45M Failed to Deliver (FTD) Shares 14,343 FTD / Avg. Volume 4.71%
Short Selling Information The latest short interest is 182.44K, so 0.44% of the outstanding
shares have been sold short.
Short Interest 182.44K Short % of Shares Out 0.44% Short % of Float 0.71% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -12.93 and the forward
PE ratio is 0.5.
LakeShore Biopharma Ltd's PEG ratio is
-0.11.
PE Ratio -12.93 Forward PE 0.5 PS Ratio 9.77 Forward PS 0.2 PB Ratio 9.58 P/FCF Ratio -16.51 PEG Ratio -0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for LakeShore Biopharma Ltd.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.13,
with a Debt / Equity ratio of 0.73.
Current Ratio 1.13 Quick Ratio 0.87 Debt / Equity 0.73 Debt / EBITDA -1.15 Debt / FCF -1.25 Interest Coverage -10.05
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $756.49K Profits Per Employee $-571.85K Employee Count 758 Asset Turnover 0.38 Inventory Turnover 0.58
Taxes Income Tax -21.73M Effective Tax Rate 4.77%
Stock Price Statistics The stock price has increased by -80.76% in the
last 52 weeks. The beta is 0.57, so LakeShore Biopharma Ltd's
price volatility has been higher than the market average.
Beta 0.57 52-Week Price Change -80.76% 50-Day Moving Average 0.99 200-Day Moving Average 1.95 Relative Strength Index (RSI) 36.49 Average Volume (20 Days) 304,203
Income Statement In the last 12 months, LakeShore Biopharma Ltd had revenue of 573.42M
and earned -433.46M
in profits. Earnings per share was -4.05.
Revenue 573.42M Gross Profit 455.73M Operating Income -445.83M Net Income -433.46M EBITDA -368.66M EBIT -410.85M Earnings Per Share (EPS) -4.05
Full Income Statement Balance Sheet The company has 246.35M in cash and 424.46M in
debt, giving a net cash position of -178.11M.
Cash & Cash Equivalents 246.35M Total Debt 424.46M Net Cash -178.11M Retained Earnings -2.31B Total Assets 1.51B Working Capital 100.94M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -295.23M
and capital expenditures -44.25M, giving a free cash flow of -339.48M.
Operating Cash Flow -295.23M Capital Expenditures -44.25M Free Cash Flow -339.48M FCF Per Share -3.17
Full Cash Flow Statement Margins Gross margin is 79.48%, with operating and profit margins of -77.75% and -75.59%.
Gross Margin 79.48% Operating Margin -77.75% Pretax Margin -79.38% Profit Margin -75.59% EBITDA Margin -64.29% EBIT Margin -77.75% FCF Margin -59.2%
Dividends & Yields LSB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for LSB.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 4, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Oct 4, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -2.42 Piotroski F-Score 3
